| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.19 | 6e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.21 | 0.0009 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.093 | 0.06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.068 | 0.2 |